The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

EDITORIAL

Current status and future perspectives for transcatheter and surgical aortic valve replacement: the role of aortic valve surgery in the era of transcatheter-based therapies

EuroIntervention 2018;14:e965-e967 published online e-edition October 2018. DOI: 10.4244/EIJV14I9A172

Department of Cardiology, The Heart Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark


Since the introduction of transcatheter aortic valve implantation (TAVI) into clinical practice, the treatment of aortic valve disease has changed dramatically. TAVI has become the treatment of choice for patients with symptomatic severe aortic valve stenosis (AS) who are at increased risk for conventional cardiac surgery. The rapid expansion of TAVI has been based upon robust clinical evidence derived from randomised controlled trials and large-scale international and national registries. Over the past decade, TAVI has evolved into a safe and effective procedure with predictable and reproducible outcomes. As a consequence, TAVI technology is increasingly used to treat patients with ...

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

What should interventional cardiologists do for patients with prediabetes?